No cost. No commitment. We'll email you when beta access is available, subject to FCA authorisation. Your responses help shape the product and support our regulatory evidence. We won't share your email with anyone.
Build this with me
FLI is built with the ADHD community, not for them. Joining the waitlist means your experience shapes what we build — from which problems we solve first to how the system communicates with you.
What happens next
Now
You're on the waitlist. Your responses contribute to our understanding of which problems to prioritise and what evidence the FCA needs to see.
When we're ready
We'll email you with beta access details. This is subject to FCA authorisation — we won't launch before the regulator is satisfied the system is safe. We'd rather be late and right than early and harmful.
During beta
You'll use Syndic on your own accounts with real money. We'll ask for your feedback. Your experience directly informs the clinical validation study and the regulatory evidence we present to the FCA.
Your data
Your email and responses are stored securely and used solely for waitlist communication and research shaping. We don't sell data. We don't share it. You can ask us to delete it at any time.
This isn't a mailing list for marketing updates. It's a research community. The people who join now shape the product that ships. That's not a line — it's the regulatory requirement. The FCA expects evidence of user involvement in product development for vulnerable customer services. Your participation is the evidence.